Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
This comprehensive resource covers product change evaluation, postmarket surveillance, audit/inspection compliance, and various other laws and regulations pertaining to maintaining a product on the market.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
| 04 June 2012 | By Ansis Helmanis
Brazil's national regulator, Anvisa, will open a public consultation on establishing quality requirements for pharmaceutical excipients used in the manufacture of medicinal products. Excipients include additives such as diluents, flavoring agents and antioxidants.
The Public Consultation No. 31, published 28 May, provides for 60 days of comment beginning June 4 2012. Comments can be submitted using the Ministry of Health's electronic system, FormSUS.
Read more:
Public Consultation No. 31
More Breaking News from RegLink
Tags: Excipients, pharmaceutical, brazil, drug